X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans

By Allyson Funk  |    June 24, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to...   Read More

Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans

By Allyson Funk  |    June 18, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to mental...   Read More

ICYMI: New Commonwealth Fund Study Shows Health Insurance Does Not Always Translate to Affordable Care

By Allyson Funk  |    May 21, 2015
A new survey from the Commonwealth Fund found nearly a quarter of 19-to-64-year-old Americans with health insurance last year—approximately 31 million people—were considered “underinsured.”...   Read More

What They Aren’t Telling You About Medicine Prices

By Holly Campbell  |    May 6, 2015
Recent cries from Bloomberg and The New York Times of “skyrocketing” medicine prices make for great headlines.  But what’s not being talked about is that these claims are based solely on the list...   Read More

What You Need to Know about the New Kaiser Poll

By Robert Zirkelbach  |    April 22, 2015
Spending on retail prescription medicines has consistently accounted for just 10 percent of health care spending, even though biopharmaceutical companies have brought more than 500 medicines to...   Read More

Patient Profile: Out-of-Pocket Cost Burden for Rheumatoid Arthritis Patient

By Allyson Funk  |    April 9, 2015
Last month, we walked through how managing chronic myeloid leukemia with a health insurance exchange plan can leave patients with burdensome out-of-pocket costs and put patients’ access to...   Read More

ICYMI: New Study Underscores Access Challenges in Essential Health Benefit Plans

By Allyson Funk  |    March 6, 2015
In the latest analysis of barriers patients face to accessing needed medicines in exchange plans, a new study published in Health Affairs found “on average…exchange plans had…higher deductibles...   Read More

Week in Review: Vaccine Myth Busters Edition

By Christian Clymer  |    February 13, 2015
The internet provides us with a wealth of information right at our fingertips, but it’s important to be mindful of misinformation, especially as it pertains to your health. With myths and facts...   Read More

Health Insurance Exchange Plans Increasingly Putting Needed Medicines Out of Reach

By Allyson Funk  |    February 11, 2015
Last year, PhRMA was joined by patient groups to highlight an analysis that found a majority of plans in health insurance exchanges required relatively high cost sharing for all medicines in at...   Read More

New Report: Forecasts for Specialty Medicines Have Been Overstated

By Jennifer Bryant  |    February 9, 2015
According to a new report from actuaries Gabriela Dieguez, Bruce Pyenson and Jennifer Carioto, at Milliman, major pharmacy benefits managers (PBMs) often overestimate future spending on specialty...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

Subscribe to Email Updates